Table 2 Comparison of characteristics according to serologically positive and negative groups
From: Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics
Positive group (n = 11) | Negative group (n = 97) | P value | |
|---|---|---|---|
Sex (male/female) | 6/5 | 61/36 | 0.74 |
Age (months) | 29 (21–70) | 24 (13–49.5) | 0.26 |
Duration of fever (days) | 6 (6–9) | 5 (5–7) | 0.092 |
Frequency of administration of IVIG | 1 (1–2) | 1 (1–1) | 0.32 |
Acute-phase coronary artery dilation; n (%) | 2 (18.18 %) | 4 (4.12 %) | 0.11 |
CS; n (%) | 2 (18.18 %) | 1 (1.03 %) | 0.027 |
Abdominal symptoms; n (%) | 8 (72.73 %) | 33 (34.02 %) | 0.02 |
White blood cell count (/μ L) | 12,900 (11,100–19,400) | 13,000 (10,750–15,400) | 0.48 |
Absolute neutrophil count (/μ L) | 8117 (5741–24,654) | 8032 (5696–10,240) | 0.73 |
Serum albumin concentration (g/dL) | 3.8 (3.4–4) | 3.7 (3.4–4) | 0.54 |
Serum total bilirubin concentration (mg/dL) | 0.4 (0.3–0.7) | 0.6 (0.4–0.8) | 0.47 |
Serum aspartate aminotransferase (U/L) | 37 (19–230) | 32.5 (25–69.25) | 0.8 |
Serum sodium (mmol/L) | 134 (133–138) | 136 (134–138) | 0.24 |
Serum CRP concentration (mg/dL) | 4.36 (1.81–8.09) | 7.09 (3.09–11.72) | 0.27 |
Serum procalcitonin concentration (ng/mL) | 0.67 (0.42–2.18) | 0.47 (0.175–1.995) | 0.37 |
N-terminal pro-brain natriuretic peptide (pg/mL) | 379 (81.75–771.5) | 386 (140–936) | 0.74 |
Serum soluble interleukin-2 receptor (U/mL) | 1560 (1350–2680) | 1635 (1062.5–2157.5) | 0.37 |
Urinary β 2-microglobulin/creatinine ratio | 101.9 (10.7–203.7) | 18.9 (5.9–126.3) | 0.25 |
High risk patients; n (%) | 3 (27.27 %) | 26 (27.08 %) | 1 |